cvti posts

Feed

Analyst Calls: ARNA, ATLS, BJ, CTVI, FO, GRMN, IRET, NI, NS, SWN, VMI ...

Analyst Upgrades

  • Goldman Sachs upgraded BJ's Wholesale (BJ) to neutral from sell and has a $43 target on the stock. Note that private equity firm Green Equity took a 9.5% stake in the company. Shares were also upgraded at Jefferies to buy from hold.
  • Stephens upgraded Covenant Transportation (CVTI) to overweight from equal weight after the company positively preannounced Q2 results. The firm raised its target for shares to $12 from $5.
  • Leerink upgraded Arena Pharmaceuticals (ARNA) to outperform from market perform after the company signed a partnership deal with Eisai for U.S. commercialization rights to lorcaserin. The firm believes the deal removes a major concern and upped its target for shares to $6 from $5.
  • Fortune Brands (FO) was upgraded to hold from sell at Citigroup.
  • KeyBanc upgraded NiSource (NI) to buy from hold.
  • Akzo Nobel (AKZOY) was upgraded to buy from neutral at UBS.

Continue reading Analyst Calls: ARNA, ATLS, BJ, CTVI, FO, GRMN, IRET, NI, NS, SWN, VMI ...

Analyst upgrades 9-4-07: KELYA, IRM, CVTI and the biotech sector

MOST NOTEWORTHY: Kelly Services, Iron Mountain, Covenant Transportation and the biotech sector were today's noteworthy upgrades:
OTHER UPGRADES:

Analyst downgrades 1-29-07: Netflix downgraded to Sell

MOST NOTEWORTHY: Netflix Inc (NFLX) was the most notable downgrade on the first trading session of the week.
  • Roth Capital downgraded Netflix Inc (NASDAQ: NFLX) to Sell from Hold, on the belief that the competitive threat of Blockbuster (NYSE: BBI) will not likely diminish in the near-term.
OTHER DOWNGRADES:
  • Deutsche Telekom ADS (NYSE: DT) was downgraded to Sell from Hold at Citigroup following the company's profit warning.
  • LECG Corp (NASDAQ: XPRT) was downgraded by William Blair to Underperform from Outperform following the company's disappointing guidance.
  • Symantec Corp (NASDAQ: SYMC) was downgraded to Source of Funds from Accumulate at ThinkEquity.
  • Stephens downgraded Covenant Transport Inc (NASDAQ: CVTI) to Equal Weight from Overweight based on the timing of a turnaround.
  • Bear Stearns downgraded shares of MGM Mirage (NYSE: MGM) to Peer Perform from Outperform citing valuation.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Analyst upgrades 1-4-07: ERTS, trucking sector upgraded

MOST NOTEWORTHY: The trucking sector, PepsiCo (PEP) and Electronic Arts (ERTS) were the most notable upgrades today.
  • Wachovia upgraded the trucking sector to Market Weight from Underweight, as they believe the negative sentiment towards the group is starting to bottom, also noting that trucking stocks tend to rally before fundamentals fully bottom. Wachovia upgraded Con-Way Inc (NYSE: CNW) and Covenant Transport 'A' NASDAQ: CVTI) to Outperform from Market Perform, and Arkansas Best (NASDAQ: ABFS), Heartland Express Inc (NASDAQ: HTLD), Werner Enterprises (NASDAQ: WERN), US Xpress Enterprises 'A' (NASDAQ: XPRSA) to Market Perform from Underperform.
  • JP Morgan added PepsiCo (NYSE: PEP) to their Focus List, as the firm believes the recent pullback due to concerns over commodities costs and margins is overdone.
  • Janco upgraded Electronic Arts (NASDAQ: ERTS) to Buy from Hold with a $69 target, citing valuation.
OTHER UPGRADES:
  • Amgen Inc (NASDAQ: AMGN) was upgraded to Outperform from Peer Perform with a $77 target at Bear Stearns; the firm views Amgen's risk/reward as favorable as the most reasonable of CERA's launch scenarios, owned by Roche Holdings AG (OTC: RHHBY), are priced into valuation, and sees significant upside if CERA does not launch.
  • Caris upgraded LSI Logic (NYSE: LSI) to Buy from Above Average with a $12 target; they believe investors are underestimating the synergies involved with the Agere Systems (NYSE: AGR) deal. The broker sees upside to earnings estimates and raised their target of LSI Logic to $12 from $11.
  • Merrill Lynch upgraded shares of ImClone Systems (NASDAQ: IMCL) to Neutral from Sell, and sees a short-term trading opportunity due to the overly negative sentiment into the upcoming sales figures. The broker thinks Imclone could meet its Erbitux sales estimates despite weak prescription data.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Symbol Lookup
IndexesChangePrice
DJIA-89.2312,801.23
NASDAQ-23.352,903.88
S&P 500-9.311,342.64

Last updated: February 11, 2012: 12:51 AM

Hot Stocks

General Electric

18.875-0.255(-1.33)

Alcoa

10.29-0.35(-3.29)

Apple Inc

493.42+0.25(+0.05)

Google Inc 'A'

605.91-5.55(-0.91)

Bank of America

8.07-0.11(-1.34)

Wal-Mart Stores

61.90-0.06(-0.10)

Exxon Mobil Corp

83.80-1.08(-1.27)

Ford

12.44-0.25(-1.97)

Citigroup

32.925-0.735(-2.18)

IBM

192.42-0.71(-0.37)

Yahoo

16.14+0.14(+0.88)

Starbucks

48.82-0.38(-0.77)

Microsoft

30.495-0.275(-0.89)

Home Depot

45.33+0.06(+0.13)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1328939505544 ms.